Delivery Order SPE2DB22D3301-SPE2DB23FY7VU
- Not listed
- This federal contract award, valued at $3,818.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,841,042 units of the pharmaceutical Citalopram HBR 40 mg tablets, with a completion date of November 17, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award is for the delivery of citalopram HBR 40 mg tablets in quantities of 500 to the Defense Logistics Agency (DLA). The contract, valued at $1,201.28, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
- This federal contract award, valued at $1,469.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,983,231 units of Citalopram HBR 40 mg tablets, a pharmaceutical product, with a completion date of May 19, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen...
- This federal contract award, valued at $1,166.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,873,359 tablets of the medication Citalopram HBR 40 mg, with a completion date of April 11, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $1,879.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,471 units of the pharmaceutical drug Citalopram HBR 40 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 30, 2024. This contract award is not designated as a set-aside and was issued through full and...
- This federal contract award, valued at $2,515.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,088,187 units of Citalopram HBR 40 mg tablets, a medication used to treat mental health conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $17,967.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Citalopram HBR 40 mg tablets in 500-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,312.23, is for the delivery of 500 bottles of Citalopram HBR 40 mg Tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,768.01 firm fixed-price delivery order is for the supply of 4,563,283,416 units of Citalopram HBR 40 mg Tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,134.80 Firm Fixed Price Delivery Order covers the supply of 4,563,417,389 units of Citalopram HBR 40 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FY7VUDelivery Order
This federal contract award, valued at $6,241.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Citalopram HBR 40 MG Tablets in 500-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order supports the DLA's procurement of essential pharmaceutical commodities to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 5/18/23 |